The Glaucoma Foundation

aka TGF   |   New York, NY   |  http://www.glaucomafoundation.org

Mission

The Glaucoma Foundation is dedicated to improving the lives of people with glaucoma. The Foundation works to encourage and support basic and applied research in glaucoma with a goal to preserve and restore vision. We strive to be an important resource to help patients, their families, and at-risk individuals to manage their glaucoma through education and outreach.

Ruling year info

1985

President and CEO

Ms. Elena Sturman

Main address

80 Maiden Lane, Suite 700

New York, NY 10038 USA

Show more contact info

EIN

13-3174839

NTEE code info

Eye (H41)

Eye Diseases, Blindness and Vision Impairments (G41)

Fund Raising and/or Fund Distribution (H12)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2019, 2018 and 2017.
Register now

Communication

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

Glaucoma is the leading cause of preventable blindness. It is estimated that 80 million people worldwide have the disease, three million in the United States. Since our founding in 1984, The Glaucoma Foundation has encouraged and supported cutting edge research with a goal to eradicate the disease and reverse blindness. Through our websites, publications, e-newsletters, and a variety of educational events, we increase awareness of glaucoma and the importance of timely and appropriate eye care.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Research and Education

The Foundation works to encourage and support basic and applied research in glaucoma, to gain and disseminate new information about the causes and treatment of glaucoma, and to further efforts to identify and develop novel approaches to preserve visual function and reverse blindness caused by glaucoma.

The Foundation’s Grant-in-Aid Program has awarded millions of dollars in seed money for cutting-edge research projects. Preliminary data from these projects have frequently been used to support proposals for larger grants from entities such as the National Institutes of Health. Beginning in 2013, TGF’s Grants Program is exclusively funding projects on a pathway to cure exfoliation syndrome.

The Glaucoma Foundation’s interdisciplinary Annual International Scientific Think Tank has brought together some of the world’s top scientists and clinicians. These gatherings continue to be a catalyst for setting the course to find new treatments and cures for glaucoma.

Headquartered in New York, TGF serves patients across the globe through its website and on-line support groups.

The organization’s “Eye to Eye” newsletter keeps thousands of households worldwide informed about research news and other developments and includes such informative features as “Doctor, I Have A Question.” An electronic newsletter is sent out bi-monthly.

Population(s) Served
Adults
People with vision impairments

Where we work

Our Sustainable Development Goals

SOURCE: Self-reported by organization

Learn more about Sustainable Development Goals.

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

The purpose of The Glaucoma Foundation is to develop a cure for glaucoma through innovative research, collaboration, and education, with integrity, intellectual curiosity, the recognition and support of innovation, and the embrace of a diversity of people and ideas.

TGF funds groundbreaking glaucoma research, historically in the areas of neuroprotection and genetics, and currently in exfoliation syndrome, the most common recognizable cause of open-angle glaucoma in the world. TGF's research grants provide a platform for large research projects now led by the National Institutes of Health as well as the pharmaceutical industry.

Held annually, The Glaucoma Foundation’s International Scientific Think Tank is a unique opportunity for scientists to apply the research and progress in other diseases and systems to the challenges of glaucoma. This interdisciplinary meeting fosters creative thought and collaboration among the world’s leading glaucoma experts, neuroscientists, geneticists, biologists, immunologists, and other specialists.

Traditionally, the two-day forum achieves three objectives:

• Orienting scientists from other fields to glaucoma.
• Presenting critical scientific findings that may impact or even redefine the future course of glaucoma research.
• Identifying novel approaches for gathering scientific data.

By encouraging new research strategies and innovative insights into the causes of glaucoma at this forum, The Glaucoma Foundation continues to spearhead the multi-disciplinary campaign to eradicate blindness from this disease.

The Foundation provides information and news through e-newsletters, our website, and educational events. We provide links to other resources including online support groups.

The Glaucoma Foundation 's board of directors, and scientific and medical advisory boards, are comprised of experts in science, medicine, and finance. We partner with other leaders in healthcare, including the NIH and pharma. We are supported by thousands of individual donors and an annual awards gala.

Since 1984, the Foundation has been providing information about eye health and glaucoma to patients and their families. We have consistently supported research that has the potential to translate basic science into treatment, potentially leading to a cure for glaucoma. For more than twenty years, we encouraged scientists working in a wide range of inquiry including micro and nanotechnology, neuroprotection, nanomedicine, tissue bioengineering, genetics, and genomics. For the past ten years, the Foundation has focused on expanding the understanding of exfoliation syndrome, the most common recognizable cause of open-angle glaucoma in the world, affecting about 80 million people, and accounting for the majority of cases in some countries.

Beginning with our first grant cycle of 2021, the Foundation will expand our scope of funding beyond exfoliation.

Our e-newsletter has more than 7,000 subscribers and we reach thousands more through educational events, the mail, and our website.

Financials

The Glaucoma Foundation
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

The Glaucoma Foundation

Board of directors
as of 7/23/2021
SOURCE: Self-reported by organization
Board chair

Dr. Gregory Harmon

Robert Ritch

Gregory Harmon

Salvatore Ciampo

Reza Dibadj

David Fellows

Murray Fingeret

Barry Friedberg

Paul Kaufman

Jeffrey Liebmann

Kumar Mahadeva

Kenneth Mortenson

Louis Pasquale

Patricia Hill

Sheldon Siegel

Irving Wolbrom

Naj Sharif

Jai Parekh

Baldo Sforzolini

Joe Rosen

Joe Rosen

Barbara Calaba

Carole Darden Lloyd

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes

Organizational demographics

SOURCE: Self-reported; last updated 7/23/2021,

Who works and leads organizations that serve our diverse communities? GuideStar partnered on this section with CHANGE Philanthropy and Equity in the Center.

Leadership

The organization's leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Female

Race & ethnicity

No data

Gender identity

No data

 

No data

Sexual orientation

No data

Disability

No data